“Imaging technology is guiding cutting edge drug development.”
Clarity Pharmaceuticals was featured in dealflow, the publication for the Entrepreneurs’ Programme which profiles some of the best performing and highest potential businesses that have received commercialisation support from the Australian Government.
“Today’s biopharmaceutical companies are under pressure to meet the demand for more personalised therapies, where drugs target an individual’s specific disease, and whole-body toxic side effects are reduced.
This is where Clarity Pharmaceuticals Pty Ltd, a Sydney-based biotechnology company, is making a difference.”
